Provided by Tiger Trade Technology Pte. Ltd.

Clover Health Corp

1.87
-0.0100-0.53%
Volume:3.02M
Turnover:5.65M
Market Cap:981.13M
PE:-11.19
High:1.90
Open:1.86
Low:1.85
Close:1.88
52wk High:3.92
52wk Low:1.85
Shares:524.67M
Float Shares:400.29M
Volume Ratio:0.67
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1671
EPS(LYR):-0.1671
ROE:-26.33%
ROA:-9.53%
PB:3.18
PE(LYR):-11.19

Loading ...

Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Major Issues Report

8-K - Current report
May 25, 2022

Major Issues Report

8-K - Current report
May 18, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 15, 2021

Correspondence

CORRESP [Cover] - Correspondence